Is Genomma Lab stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Genomma Lab pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Friday 13th of September 2024 were paid MXN0.2 per share. Over the last 11 times between 2021 and 2024, Genomma Lab has paid MXN3.2888 with an average of MXN0.3 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Genomma Lab 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was MXN19.05, you would have made a profit of MXN5.95 per share or 31.23%
Yes, the average daily trading liquidity for Genomma Lab is MXN4.24 million. You should therefore be able to get in and out of your positions relatively fast.
Genomma Lab has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.28, the company's ability to pay off the debt is normal. Genomma Lab has a good net profit margin of 7.83% and should have high tolerances against inflation.
We have calculated the inflation risk for Genomma Lab to be low [0.4 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.